Three things to know:
1. Ms. Schulzki previously held leadership positions at Stryker, DePuy Synthes and N Spine.
2. As senior vice president of business and evidence development at Tissue Regeneration Systems, she led the company’s exit to DePuy Synthes and the licensing of its mineral coating technology to Medtronic Spine.
3. Carlsmed is leveraging artificial intelligence and predictive analytics to use prior outcomes data for personalizing the treatment of complex adult spinal deformities.
More articles on devices:
Dr. Sergiy Nesterenko opens spine clinic in Texas
California hospital adds 7 neurosurgeons to curb patient leakage
Drs. Nic Gay, Kerisimasi Reynolds team to form Silicon Valley Orthopaedics
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.